share_log

Oppenheimer Maintains Outperform on Rentokil Initial, Raises Price Target to $47

Benzinga ·  May 22, 2023 08:45

Oppenheimer analyst Ian Zaffino maintains Rentokil Initial (NYSE:RTO) with a Outperform and raises the price target from $40 to $47.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment